MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CRBP had $11,294K increase in cash & cash equivalents over the period. -$64,498K in free cash flow.

Cash Flow Overview

Change in Cash
$11,294K
Free Cash flow
-$64,498K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from sales and maturiti...
    • Proceeds from issuance of common...
    • Increase (decrease) in accrued e...
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Net loss
    • (decrease) increase in accounts ...
    • Others

Cash Flow
2025-12-31
Net loss
-78,537
Stock-based compensation expense
6,288
Depreciation expense
233
Net amortization of premiums and discounts on investments
1,366
Amortization of debt discount
0
Other
229
Decrease (increase) in prepaid expenses and other current assets
-634
Decrease in other assets
0
Decrease in operating lease right-of-use asset
-1,051
Decrease in other long-term liabilities
0
(decrease) increase in accounts payable
-2,349
Increase (decrease) in accrued expenses
11,390
Decrease in operating lease liabilities
-1,606
Net cash used in operating activities
-64,491
Purchases of property and equipment
7
Purchases of investments
163,091
Proceeds from sales and maturities of investments
161,457
Net cash used in investing activities
-1,641
Proceeds from issuance of common stock and pre-funded warrants, net
77,426
Repayment of short-term borrowings
0
Repayment of long-term borrowings
0
Net cash provided by (used in) financing activities
77,426
Net increase in cash, cash equivalents, and restricted cash
11,294
Cash, cash equivalents, and restricted cash at beginning of the period
17,868
Cash, cash equivalents, and restricted cash at end of the period
29,162
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock and...$77,426K Net cash provided by(used in) financing...$77,426K Net increase incash, cash...$11,294K Canceled cashflow$66,132K Increase (decrease) inaccrued expenses$11,390K Stock-based compensationexpense$6,288K Decrease in operatinglease right-of-use...-$1,051K Decrease (increase) inprepaid expenses and...-$634K Depreciation expense$233K Proceeds from sales andmaturities of investments$161,457K Net cash used inoperating activities-$64,491K Net cash used ininvesting activities-$1,641K Canceled cashflow$19,596K Canceled cashflow$161,457K Net loss-$78,537K Purchases of investments$163,091K (decrease) increase inaccounts payable-$2,349K Decrease in operatinglease liabilities-$1,606K Net amortization ofpremiums and discounts on...$1,366K Other$229K Purchases of property andequipment$7K

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (CRBP)